Bilateral acute iris transillumination (BAIT) syndrome: literature review

References

• Bringas Calvo R, Iglesias Cortiñas D. [Acute and bilateral uveitis secondary to moxifloxacin]. Arch Soc Esp Oftalmol. 2004;79(7):357–359.
   PubMedGoogle Scholar
• Wefers Bettink-Remeijer M, Brouwers K, van Langenhove L, et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond). 2009;23(12):2260–2262. doi:10.1038/eye.2009.234
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Garip A, et al. Bilateral acute iris transillumination. Arch Ophthalmol. 2011;129(10):1312–1319. doi:10.1001/archophthalmol.2011.310
   PubMedGoogle Scholar
• Jang L, Borruat F-X, Guex-Crosier Y. Bilateral acute iris transillumination: a rare cause of iris atrophy. report of 2 cases. Klin Monbl Augenheilkd. 2015;232(4):593–594. doi:10.1055/s-0035-1545744
   PubMed Web of Science ®Google Scholar
• Gonul S, Bozkurt B, Okudan S, Tugal-Tutkun I. Bilateral acute iris transillumination following a fumigation therapy: a village-based traditional method for the treatment of ophthalmomyiasis. Cutan Ocul Toxicol. 2015;34(1):80–83. doi:10.3109/15569527.2014.886589
   PubMed Web of Science ®Google Scholar
• Degirmenci C, Guven Yilmaz S, Palamar M, Ates H. Bilateral acute iris transillumination: case report. Saudi J Ophthalmol. 2016;30(2):122–124. doi:10.1016/j.sjopt.2015.11.009
   PubMedGoogle Scholar
• Perone JM, Reynders S, Sujet-Perone N, et al. Le syndrome de transillumination bilatérale aiguë de l’iris: case report [Bilateral acute iris transillumination: case report]. J Fr Ophtalmol. 2017;40(8):713-716. French. doi:10.1016/j.jfo.2017.01.018
   Google Scholar
• Gonul S, Bozkurt B. Bilateral acute iris transillumination (BAIT) initially misdiagnosed as acute iridocyclitis. Arq Bras Oftalmol. 2015;78(2):115–117. doi:10.5935/0004-2749.20150029
   PubMed Web of Science ®Google Scholar
• Kawali A, Mahendradas P, Shetty R. Acute depigmentation of the iris: a retrospective analysis of 22 cases. Can J Ophthalmol. 2019;54(1):33–39. doi:10.1016/j.jcjo.2018.03.020
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Urgancioglu M. Bilateral acute depigmentation of the iris. Graefes Arch Clin Exp Ophthalmol. 2006;244(6):742–746. doi:10.1007/s00417-005-0137-x
   PubMed Web of Science ®Google Scholar
• Hinkle DM, Dacey MS, Mandelcorn E, et al. Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol. 2012;31(2):111–116. doi:10.3109/15569527.2011.617024
   PubMed Web of Science ®Google Scholar
• Kreps EO, Hondeghem K, Augustinus A, et al. Is oral moxifloxacin associated with bilateral acute iris transillumination? Acta Ophthalmol. 2017. doi:10.1111/aos.13558
   Web of Science ®Google Scholar
• Tranos P, Lokovitis E, Masselos S, Kozeis N, Triantafylla M, Markomichelakis N. Bilateral acute iris transillumination following systemic administration of antibiotics. Eye (Lond). 2018;32(7):1190–1196. doi:10.1038/s41433-018-0054-y
   PubMed Web of Science ®Google Scholar
• Morshedi RG, Bettis DI, Moshirfar M, Vitale AT. Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature. Ocul Immunol Inflamm. 2012;20(4):266–272. doi:10.3109/09273948.2012.670359
   PubMed Web of Science ®Google Scholar
• Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002;65(3):455–464.
   PubMed Web of Science ®Google Scholar
• DeLaney MC. Risks associated with the use of fluoroquinolones. Br J Hosp Med (Lond). 2018;79(10):552–555. doi:10.12968/hmed.2018.79.10.552
   Web of Science ®Google Scholar
• Fraunfelder FW, Fraunfelder FT. Diplopia and fluoroquinolones. Ophthalmology. 2009;116(9):1814–1817. doi:10.1016/j.ophtha.2009.06.027
   Web of Science ®Google Scholar
• Knape RM, Sayyad FE, Davis JL. Moxifloxacin and bilateral acute iris transillumination. J Ophthalmic Inflamm Infect. 2013;3(1):10. doi:10.1186/1869-5760-3-10
   PubMedGoogle Scholar
• Duncombe A, Gueudry J, Massy N, Chapuzet C, Gueit I, Muraine M. [Severe pseudouveitis associated with moxifloxacin therapy]. J Fr Ophtalmol. 2013;36(2):146–150. doi:10.1016/j.jfo.2012.07.002
   Web of Science ®Google Scholar
• Siefert HM, Domdey-Bette A, Henninger K, Hucke F, Kohlsdorfer C, Stass HH. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J Antimicrob Chemother. 1999;43(Suppl):B:69–76. doi:10.1093/jac/43.suppl_2.69
   Web of Science ®Google Scholar
• Perin A, Lyzogubov VV, Bora NS, Morshedi G. In vitro assessment of moxifloxacin toxicity to human iris pigment epithelium. Invest Ophthalmol Vis Sci. 2015;56(7): 5729–5729.
   Web of Science ®Google Scholar
• Mahanty S, Kawali AA, Dakappa SS, et al. Aqueous humor tyrosinase activity is indicative of iris melanocyte toxicity. Exp Eye Res. 2017;162:79–85. doi:10.1016/j.exer.2017.07.006
   PubMed Web of Science ®Google Scholar
• Den Beste KA, Okeke C. Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: a case report. Medicine (Baltimore). 2017;96(43):e7936. doi:10.1097/MD.0000000000007936
   PubMed Web of Science ®Google Scholar
• Maestrini HA, Maestrini AA, Machado DDO, Santos DVV, Almeida HGD. Bilateral acute depigmentation of the iris (BADI): first reported case in Brazil. Arq Bras Oftalmol. 2013;76(1):42–44.
   Web of Science ®Google Scholar
• Altan C, Basarir B, Kesim C. An unexpected complication in bilateral acute iris transillumination: cystoid macular edema. Indian J Ophthalmol. 2018;66(6):869–871. doi:10.4103/ijo.IJO_1134_17
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Araz B, Taskapili M, et al. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients. Ophthalmology. 2009;116(8):1552–1557, 1557.e1. doi:10.1016/j.ophtha.2009.02.019
   PubMed Web of Science ®Google Scholar
• Hernández Pardines F, Serra Verdú MC, Font Juliá E, Molina Martin JC. Aqueous humor misdirection syndrome after glaucoma filtering surgery in patient with bilateral acute iris transillumination (BAIT) syndrome. Arch Soc Esp Oftalmol. 2018;93(9):444–446. doi:10.1016/j.oftal.2018.03.010
   PubMedGoogle Scholar
• Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma–a major review. Clin Experiment Ophthalmol. 2008;36(9):868–882. doi:10.1111/j.1442-9071.2009.01920.x
   PubMed Web of Science ®Google Scholar
• Konstas AGP, Ringvold A. Epidemiology of Exfoliation Syndrome. J Glaucoma. 2018;27(Suppl 1):S4–S11. doi:10.1097/IJG.0000000000000908
   Google Scholar
• Aboobakar IF, Johnson WM, Stamer WD, Hauser MA, Allingham RR. Major review: exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology. Exp Eye Res. 2017;154:88–103. doi:10.1016/j.exer.2016.11.011
   PubMed Web of Science ®Google Scholar
• Siverio Júnior CD, Imai Y, Cunningham ET. Diagnosis and management of herpetic anterior uveitis. Int Ophthalmol Clin. 2002;42(1):43–48.
   Google Scholar
• Bodaghi B. [Viral uveitis]. J Fr Ophtalmol. 2004;27(5):528–537.
   Web of Science ®Google Scholar
• Sève P, Cacoub P, Bodaghi B, et al. Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev. 2017;16(12):1254–1264. doi:10.1016/j.autrev.2017.10.010
   PubMed Web of Science ®Google Scholar